Source: The Zimbabwean

HARARE, Zimbabwe – Zimbabwe has approved the use and import of the anti-parasite drug Ivermectin to treat COVID-19 patients.

“In these difficult times of COVID-19 treatment, we have to be careful to protect patients as well as not to deny them effective treatment regimes,” said a statement by the Health Ministry addressed to the Medicines Control Authority of Zimbabwe (MCAZ).

“It is in this regard, the authority is hereby granted for you to proceed to allow importation and use of these medicines under the supervision and guidance you outlined. Ivermectin can be evaluated for both treatment and prophylaxis,” the ministry said.

This ministry’s decision comes a few days after the deaths of three cabinet ministers and several top government officials from COVID-19 in a short period of time.

Owing to the fact that Ivermectin was not registered for use in Zimbabwe, COVID-19 patients ended up using the Ivermectin product meant for animals.

While some revealed that the animal drug worked for them, the government warned that it causes serious side effects in humans.

A veterinary expert who spoke on condition of anonymity confirmed the covert use of Ivermectin by COVID-19 patients and that one 5 millimeter shot was selling for US$5 (1,809 Zimbabwe dollars).

Two weeks ago, the medicines control body threatened to arrest anyone found to be administering Ivermectin to humans. MCAZ Director General Richard Rukwata was quoted in the local media expressing concern that the animal drug was not registered.

Zimbabwe has to date recorded 32,304 COVID-19 cases, including 1,122 deaths and 23,687 recoveries, according to the Ministry of Health.





Related: HCQ and Ivermectin included in multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19

COVID-19: A realistic approach to community management – HCQ & IVM in concert with vaccination

Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.

Ivermectin for Covid-19: Database of all Ivermectin COVID-19 studies – 35 trials and growing

Use of Ivermectin as a potential chemoprophylaxis for COVID-19 in Egypt : A randomised clinical trial

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Trouble in Paradise Surrounding the use of Ivermectin

In nations around the world tension mounts between physicians and caregivers seeking to prescribe what they professionally deem as safe doses of ivermectin, as an off-label treatment for COVID-19 and national health authorities, which for the most part have all taken a hostile and oppositional position against the use of the drug.

Read More »

How Ivermectin became a Target for the ‘Fraud Detectives.’

And why is ivermectin being so negatively targeted by Big Tech and Big Media? One could argue conflict of interest plays a major role, given how intertwined they are with Big Pharma and the far-reaching grasp of the BMGF. A cheap and effective early treatment for Covid-19, like ivermectin, can be seen as a significant threat to the financial interests of those involved with Covid vaccines and expensive anti-viral drugs.

Read More »

Canada: Alberta Failing on COVID-19 Vaccines and Treatment

Numerous studies and clinical observation of thousands of patients has indicated that Ivermectin is highly effective in this regard. Even low dose studies that were designed to reach the conclusion that ivermectin was not effective found a signal that indicated that Ivermectin effectively interacted with the COVID virus molecule to prevent or lessen replication of the virus.”

Read More »